Global University Venturing

The commercialisation firm will cut cash operating expenses by more than 40% year-on-year, while SciFluor Life and Precision Biopsy received $9m in financing between them.

The UW-founded healthcare forecasting software developer has collected $30.5m in all from backers including OUP and a unit of compliance firm UL.

The fund has an annual budget of $400,000 and will complement two other schemes under the university Chancellor’s Fund for Innovation and Collaboration.

Indiana University has retooled its entrepreneurial support offering to enhance its services in business case development, executive recruitment and the sourcing of capital.

Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a Boston University-operated body and a $8.5m series A round.

Building on research by a former University of Minnesota professor, Torigen Pharmaceuticals has begun in-veterinary testing of its immunooncology vaccine for companion animals.

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

NYU and Allied Minds-founded Ram technology developer Spin Memory has unveiled deep tech-focused VC firm Abies Ventures as an investor in a $52m series B first announced late last year.

Dianomi Therapeutics will work with Ligand on a medication delivery platform based on research from University of Wisconsin-Madison initially targeting pain disorders and osteoarthritis.

UC Berkeley will offer participants up to $200,000 from its X-Fund as it looks to build a blockchain ecosystem connecting resources from university departments, Silicon Valley and further afield.

Nan Fung Life Sciences and Novo have taken part in a series B round for Stanford's immuno-oncology drug developer Bolt Biotherapeutics.